Breaking News Instant updates and real-time market news.

DPW

DPW Holdings

$1.98 /

-0.33 (-14.29%)

06:38
09/28/20
09/28
06:38
09/28/20
06:38

DPW Holdings explores potential rights offering to grow Coolisys EV charger unit

DPW Holdings announced that it is exploring the possibility of conducting a public subscription rights offering that could involve the issuance to its shareholders a dividend in the form of a basic subscription right and over-subscription privilege to purchase shares of its capital stock and/or other securities. The company is considering offering any or all of the following securities: common stock, dividend-yielding preferred stock and warrants to purchase common stock. In particular, the company is considering offering purchasers of its securities in the rights offering the right to exchange such securities for ownership of its power electronics subsidiary, Coolisys Technologies, if and when Coolisys effects an initial public offering of its shares or other going public transaction such as a spin-off. The offering of the securities in the rights offering would be made pursuant to a registration statement on Form S1 to be filed with the U.S. SEC. DPW intends to use a significant portion of any net proceeds of the potential rights offering to accelerate the growth of Coolisys' electric vehicle charger business. The company intends to gauge feedback and interest for the potential rights offering from institutional accredited investors and qualified institutional buyers.

  • 08

    Oct

TODAY'S FREE FLY STORIES

Periodicals
Samsung chairman dies at 78, WSJ reports » 06:21
10/26/20
10/26
06:21
10/26/20
06:21
SSNLF

Samsung

$0.00 /

+ (+0.00%)

Samsung Chairman Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSNLF Samsung
$0.00 /

+ (+0.00%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

10/01/20 KeyBanc
No major surprises around Google's device launches, says KeyBanc
09/21/20 Susquehanna
Samsung upgraded to Positive from Neutral at Susquehanna
09/09/20 Loop Capital
Qorvo price target raised to $155 from $147 at Loop Capital
09/08/20 Raymond James
Nokia downgraded to Market Perform from Strong Buy at Raymond James
SSNLF Samsung
$0.00 /

+ (+0.00%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

Downgrade
Cabot Oil & Gas downgraded to Neutral from Buy at BofA » 06:21
10/26/20
10/26
06:21
10/26/20
06:21
COG

Cabot Oil & Gas

$19.69 /

-0.48 (-2.38%)

BofA analyst Doug Leggate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COG Cabot Oil & Gas
$19.69 /

-0.48 (-2.38%)

COG Cabot Oil & Gas
$19.69 /

-0.48 (-2.38%)

09/24/20 Tudor Pickering
Cabot Oil & Gas upgraded to Buy from Hold at Tudor Pickering
09/14/20 Northland
Cabot Oil & Gas initiated with a Market Perform at Northland
08/04/20 Credit Suisse
Cabot Oil & Gas assumed with a Neutral at Credit Suisse
07/23/20 Mizuho
Cabot Oil & Gas initiated with Neutral on valuation at Mizuho
COG Cabot Oil & Gas
$19.69 /

-0.48 (-2.38%)

COG Cabot Oil & Gas
$19.69 /

-0.48 (-2.38%)

Upgrade
Range Resources upgraded to Buy from Neutral at BofA » 06:21
10/26/20
10/26
06:21
10/26/20
06:21
RRC

Range Resources

$9.10 /

-0.29 (-3.09%)

BofA upgraded Range…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RRC Range Resources
$9.10 /

-0.29 (-3.09%)

RRC Range Resources
$9.10 /

-0.29 (-3.09%)

10/21/20 Raymond James
Range Resources upgraded to Market Perform from Underperform at Raymond James
10/08/20 Stifel
Range Resources resumed with a Hold at Stifel
09/24/20
Fly Intel: Top five analyst downgrades
09/24/20 Goldman Sachs
Range Resources downgraded to Sell from Neutral at Goldman Sachs
RRC Range Resources
$9.10 /

-0.29 (-3.09%)

RRC Range Resources
$9.10 /

-0.29 (-3.09%)

RRC Range Resources
$9.10 /

-0.29 (-3.09%)

RRC Range Resources
$9.10 /

-0.29 (-3.09%)

Upgrade
Independent Bank upgraded to Buy from Neutral at Compass Point » 06:21
10/26/20
10/26
06:21
10/26/20
06:21
INDB

Independent Bank

$58.13 /

+2.54 (+4.57%)

Compass Point analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INDB Independent Bank
$58.13 /

+2.54 (+4.57%)

06/24/20 Piper Sandler
Independent Bank downgraded to Neutral from Overweight at Piper Sandler
06/08/20 DA Davidson
Independent Bank downgraded to Neutral from Buy at DA Davidson
06/08/20 DA Davidson
Independent Bank downgraded to Neutral from Buy at DA Davidson
03/16/20 DA Davidson
Independent Bank upgraded to Buy from Neutral at DA Davidson
INDB Independent Bank
$58.13 /

+2.54 (+4.57%)

Earnings
Otis Worldwide raises FY20 adj. EPS view to $2.42 from $2.20-$2.30 » 06:20
10/26/20
10/26
06:20
10/26/20
06:20
OTIS

Otis Worldwide

$63.46 /

+0.175 (+0.28%)

Consensus $2.30. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTIS Otis Worldwide
$63.46 /

+0.175 (+0.28%)

OTIS Otis Worldwide
$63.46 /

+0.175 (+0.28%)

10/07/20 JPMorgan
Otis Worldwide price target raised to $79 from $75 at JPMorgan
09/24/20 Wolfe Research
Otis Worldwide upgraded to Outperform from Peer Perform at Wolfe Research
09/24/20 JPMorgan
Otis Worldwide pullback due to 'unwarranted concerns,' says JPMorgan
07/29/20 Credit Suisse
Otis Worldwide price target raised to $66 from $55 at Credit Suisse
OTIS Otis Worldwide
$63.46 /

+0.175 (+0.28%)

Recommendations
Revance price target raised to $38 from $35 at Barclays » 06:20
10/26/20
10/26
06:20
10/26/20
06:20
RVNC

Revance

$25.33 /

+1.45 (+6.07%)

Barclays analyst Balaji…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RVNC Revance
$25.33 /

+1.45 (+6.07%)

RVNC Revance
$25.33 /

+1.45 (+6.07%)

10/15/20 H.C. Wainwright
Revance price target raised to $33 from $27 at H.C. Wainwright
09/28/20 Barclays
Revance price target raised to $35 from $32 at Barclays
08/11/20 Mizuho
Revance assumed with a Buy at Mizuho
06/04/20 William Blair
William Blair dermatologist survey 'clearly positive' for Revance
RVNC Revance
$25.33 /

+1.45 (+6.07%)

  • 04
    Dec
Recommendations
Elanco price target raised to $35 from $25 at Barclays » 06:20
10/26/20
10/26
06:20
10/26/20
06:20
ELAN

Elanco

$31.42 /

+0.28 (+0.90%)

Barclays analyst Balaji…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELAN Elanco
$31.42 /

+0.28 (+0.90%)

ELAN Elanco
$31.42 /

+0.28 (+0.90%)

10/01/20 Citi
Elanco price target raised to $32 from $27 at Citi
09/10/20 Cleveland Research
Elanco second half trends looking soft, says Cleveland Research
08/20/20
Fly Intel: Top five analyst upgrades
08/20/20 Morgan Stanley
Elanco upgraded at Morgan Stanley on compelling long-term prospects
ELAN Elanco
$31.42 /

+0.28 (+0.90%)

  • 23
    Jan
ELAN Elanco
$31.42 /

+0.28 (+0.90%)

ELAN Elanco
$31.42 /

+0.28 (+0.90%)

ELAN Elanco
$31.42 /

+0.28 (+0.90%)

Upgrade
Umicore upgraded to Hold from Reduce at Kepler Cheuvreux » 06:19
10/26/20
10/26
06:19
10/26/20
06:19
UMICY

Umicore

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UMICY Umicore
$0.00 /

+ (+0.00%)

08/12/20 UBS
Umicore price target lowered to EUR 33 from EUR 35 at UBS
08/03/20 Deutsche Bank
Umicore H1 results a beat, says Deutsche Bank
08/03/20 Credit Suisse
Umicore earnings estimates updated at Credit Suisse
07/14/20 Morgan Stanley
Umicore price target raised to EUR 28 from EUR 25 at Morgan Stanley
Recommendations
Bausch Health price target raised to $29 from $28 at Barclays » 06:19
10/26/20
10/26
06:19
10/26/20
06:19
BHC

Bausch Health

$18.36 /

+0.36 (+2.00%)

Barclays analyst Balaji…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$18.36 /

+0.36 (+2.00%)

BHC Bausch Health
$18.36 /

+0.36 (+2.00%)

09/17/20
Fly Intel: Top five analyst upgrades
09/17/20 BofA
Bausch Health upgraded to Neutral from Underperform at BofA
08/24/20 JPMorgan
Bausch Health shares can double into separation, says JPMorgan
08/24/20 H.C. Wainwright
Bausch Health price target lowered to $50 from $64 at H.C. Wainwright
BHC Bausch Health
$18.36 /

+0.36 (+2.00%)

BHC Bausch Health
$18.36 /

+0.36 (+2.00%)

BHC Bausch Health
$18.36 /

+0.36 (+2.00%)

Recommendations
GSX Techedu price target lowered to $66 from $77 at Barclays » 06:19
10/26/20
10/26
06:19
10/26/20
06:19
GSX

GSX Techedu

$67.36 /

-2.57 (-3.68%)

Barclays analyst Gregory…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSX GSX Techedu
$67.36 /

-2.57 (-3.68%)

GSX GSX Techedu
$67.36 /

-2.57 (-3.68%)

10/22/20
Fly Intel: Top five analyst downgrades
10/22/20 Nomura
Nomura downgrades GSX Techedu to Reduce, cuts target to 'Street-low' $38
10/22/20 Nomura
GSX Techedu downgraded to Reduce from Neutral at Nomura
10/21/20
Fly Intel: Top five analyst downgrades
GSX GSX Techedu
$67.36 /

-2.57 (-3.68%)

  • 21
    Nov
GSX GSX Techedu
$67.36 /

-2.57 (-3.68%)

GSX GSX Techedu
$67.36 /

-2.57 (-3.68%)

GSX GSX Techedu
$67.36 /

-2.57 (-3.68%)

Recommendations
Jazz Pharmaceuticals price target raised to $225 from $205 at Barclays » 06:19
10/26/20
10/26
06:19
10/26/20
06:19
JAZZ

Jazz Pharmaceuticals

$150.09 /

-1.21 (-0.80%)

Barclays analyst Balaji…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JAZZ Jazz Pharmaceuticals
$150.09 /

-1.21 (-0.80%)

JAZZ Jazz Pharmaceuticals
$150.09 /

-1.21 (-0.80%)

10/22/20 BofA
Jazz Pharmaceuticals added to US 1 List at BofA
10/20/20 Truist
Jazz Pharmaceuticals price target raised to $175 from $157 at Truist
10/09/20 Jefferies
Jazz Pharmaceuticals price target raised to $188 from $151 at Jefferies
09/14/20
Fly Intel: Top five analyst downgrades
JAZZ Jazz Pharmaceuticals
$150.09 /

-1.21 (-0.80%)

JAZZ Jazz Pharmaceuticals
$150.09 /

-1.21 (-0.80%)

Initiation
Orphazyme initiated with a Buy at Guggenheim » 06:18
10/26/20
10/26
06:18
10/26/20
06:18
ORPH

Orphazyme

$10.06 /

-0.175 (-1.71%)

Guggenheim analyst Yatin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORPH Orphazyme
$10.06 /

-0.175 (-1.71%)

06:12 Today BofA
Orphazyme initiated with a Buy at BofA
06:03 Today BofA
Orphazyme initiated with a Buy at BofA
  • 29
    Sep
ORPH Orphazyme
$10.06 /

-0.175 (-1.71%)

Earnings
Otis Worldwide reports Q3 adj. EPS 69c, consensus 56c » 06:18
10/26/20
10/26
06:18
10/26/20
06:18
OTIS

Otis Worldwide

$63.46 /

+0.175 (+0.28%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTIS Otis Worldwide
$63.46 /

+0.175 (+0.28%)

OTIS Otis Worldwide
$63.46 /

+0.175 (+0.28%)

10/07/20 JPMorgan
Otis Worldwide price target raised to $79 from $75 at JPMorgan
09/24/20 Wolfe Research
Otis Worldwide upgraded to Outperform from Peer Perform at Wolfe Research
09/24/20 JPMorgan
Otis Worldwide pullback due to 'unwarranted concerns,' says JPMorgan
07/29/20 Credit Suisse
Otis Worldwide price target raised to $66 from $55 at Credit Suisse
OTIS Otis Worldwide
$63.46 /

+0.175 (+0.28%)

Recommendations
Husky Energy rating changed to Tenger from Sector Perform at National Bank » 06:16
10/26/20
10/26
06:16
10/26/20
06:16
HUSKF

Husky Energy

$0.00 /

+ (+0.00%)

, CVE

Cenovus Energy

$3.72 /

-0.03 (-0.80%)

National Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUSKF Husky Energy
$0.00 /

+ (+0.00%)

CVE Cenovus Energy
$3.72 /

-0.03 (-0.80%)

HUSKF Husky Energy
$0.00 /

+ (+0.00%)

10/20/20 Morgan Stanley
Husky Energy price target lowered to C$4 from C$6 at Morgan Stanley
10/16/20 National Bank
Husky Energy price target lowered to C$4 from C$6 at National Bank
09/03/20 Goldman Sachs
Husky Energy assumed with a Sell at Goldman Sachs
09/02/20 Barclays
Husky Energy initiated with an Equal Weight at Barclays
CVE Cenovus Energy
$3.72 /

-0.03 (-0.80%)

10/20/20 Morgan Stanley
Cenovus Energy price target lowered to C$6 from C$8 at Morgan Stanley
10/16/20 National Bank
Cenovus Energy price target lowered to C$8 from C$11 at National Bank
10/01/20
Fly Intel: Top five analyst downgrades
10/01/20 JPMorgan
Cenovus downgraded to Underweight on valuation, leverage at JPMorgan
HUSKF Husky Energy
$0.00 /

+ (+0.00%)

CVE Cenovus Energy
$3.72 /

-0.03 (-0.80%)

CVE Cenovus Energy
$3.72 /

-0.03 (-0.80%)

Upgrade
Kontoor Brands upgraded to Buy from Neutral at BofA » 06:15
10/26/20
10/26
06:15
10/26/20
06:15
KTB

Kontoor Brands

$32.62 /

+0.48 (+1.49%)

BofA analyst Heather…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KTB Kontoor Brands
$32.62 /

+0.48 (+1.49%)

KTB Kontoor Brands
$32.62 /

+0.48 (+1.49%)

06:04 Today BofA
Kontoor Brands upgraded to Buy from Underperform at BofA
10/13/20 Piper Sandler
Kontoor Brands price target raised to $36 from $29 at Piper Sandler
10/07/20 Barclays
Barclays upgrades Retail sector to Positive, makes seven rating changes
10/07/20 Barclays
Kontoor Brands upgraded to Overweight from Equal Weight at Barclays
KTB Kontoor Brands
$32.62 /

+0.48 (+1.49%)

Initiation
Pulmonx initiated with an Equal Weight at Wells Fargo » 06:14
10/26/20
10/26
06:14
10/26/20
06:14
LUNG

Pulmonx

$42.02 /

-0.61 (-1.43%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 01
    Oct
LUNG Pulmonx
$42.02 /

-0.61 (-1.43%)

Recommendations
Turning Point Therapeutics price target raised to $130 from $100 at H.C. Wainwright » 06:13
10/26/20
10/26
06:13
10/26/20
06:13
TPTX

Turning Point Therapeutics

$102.72 /

+0.82 (+0.80%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TPTX Turning Point Therapeutics
$102.72 /

+0.82 (+0.80%)

TPTX Turning Point Therapeutics
$102.72 /

+0.82 (+0.80%)

10/25/20 Oppenheimer
Turning Point Therapeutics price target raised to $120 from $90 at Oppenheimer
09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
08/21/20 Canaccord
Turning Point Therapeutics price target raised to $85 from $80 at Canaccord
08/19/20 Roth Capital
Turning Point Therapeutics price target raised to $77 from $75 at Roth Capital
TPTX Turning Point Therapeutics
$102.72 /

+0.82 (+0.80%)

  • 19
    May
Recommendations
Viela Bio price target lowered to $75 from $82 at H.C. Wainwright » 06:12
10/26/20
10/26
06:12
10/26/20
06:12
VIE

Viela Bio

$32.60 /

+0.62 (+1.94%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIE Viela Bio
$32.60 /

+0.62 (+1.94%)

VIE Viela Bio
$32.60 /

+0.62 (+1.94%)

07/15/20 Goldman Sachs
Viela Bio upgraded to Neutral from Sell at Goldman Sachs
06/12/20 Piper Sandler
Piper says competitive updates present 'very little' potential impact on Alexion
06/12/20 H.C. Wainwright
Viela Bio price target raised to $76 from $70 at H.C. Wainwright
06/09/20
Fly Intel: Top five analyst initiations
VIE Viela Bio
$32.60 /

+0.62 (+1.94%)

  • 28
    May
Initiation
Orphazyme initiated with a Buy at BofA » 06:12
10/26/20
10/26
06:12
10/26/20
06:12
ORPH

Orphazyme

$10.06 /

-0.175 (-1.71%)

BofA analyst Tazeen Ahmad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORPH Orphazyme
$10.06 /

-0.175 (-1.71%)

06:03 Today BofA
Orphazyme initiated with a Buy at BofA
  • 29
    Sep
ORPH Orphazyme
$10.06 /

-0.175 (-1.71%)

Recommendations
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright » 06:11
10/26/20
10/26
06:11
10/26/20
06:11
RVMD

Revolution Medicines

$40.39 /

+1.17 (+2.98%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RVMD Revolution Medicines
$40.39 /

+1.17 (+2.98%)

RVMD Revolution Medicines
$40.39 /

+1.17 (+2.98%)

09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
05/21/20
Fly Intel: Top five analyst initiations
05/21/20 H.C. Wainwright
Revolution Medicines initiated with a Buy at H.C. Wainwright
03/09/20
Fly Intel: Top five analyst initiations
RVMD Revolution Medicines
$40.39 /

+1.17 (+2.98%)

  • 09
    Jul
  • 13
    Feb
RVMD Revolution Medicines
$40.39 /

+1.17 (+2.98%)

Initiation
Inter Pipeline initiated with an Equal Weight at Wells Fargo » 06:11
10/26/20
10/26
06:11
10/26/20
06:11
IPPLF

Inter Pipeline

$0.00 /

+ (+0.00%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IPPLF Inter Pipeline
$0.00 /

+ (+0.00%)

10/22/20 Canaccord
Inter Pipeline price target lowered to C$14 from C$16 at Canaccord
10/20/20 CIBC
Inter Pipeline price target raised to C$14 from C$13.50 at CIBC
09/29/20 Raymond James
Inter Pipeline price target raised to C$13 from C$12 at Raymond James
09/23/20 National Bank
Inter Pipeline price target raised to C$14 from C$13 at National Bank
Recommendations
Mirati Therapeutics price target raised to $238 from $222 at H.C. Wainwright » 06:10
10/26/20
10/26
06:10
10/26/20
06:10
MRTX

Mirati Therapeutics

$180.37 /

+0.13 (+0.07%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

05:07 Today Piper Sandler
Mirati Therapeutics price target raised to $210 from $170 at Piper Sandler
05:05 Today Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/21/20 BMO Capital
Mirati Therapeutics price target raised to $176 from $101 at BMO Capital
10/08/20 Credit Suisse
Mirati Therapeutics price target raised to $190 from $140 at Credit Suisse
MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

  • 10
    Jan
Initiation
ImmunoGen assumed with a Buy at H.C. Wainwright » 06:09
10/26/20
10/26
06:09
10/26/20
06:09
IMGN

ImmunoGen

$5.46 /

-0.06 (-1.09%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMGN ImmunoGen
$5.46 /

-0.06 (-1.09%)

IMGN ImmunoGen
$5.46 /

-0.06 (-1.09%)

10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
10/05/20 Piper Sandler
Piper says r/r BPDCN revenue opportunity for ImmunoGen's 632 'an open question'
10/02/20 Guggenheim
ImmunoGen upgraded to Buy from Neutral at Guggenheim
09/29/20 JPMorgan
ImmunoGen resumed with a Neutral at JPMorgan
IMGN ImmunoGen
$5.46 /

-0.06 (-1.09%)

  • 21
    Jan
IMGN ImmunoGen
$5.46 /

-0.06 (-1.09%)

Upgrade
TechnipFMC upgraded to Buy from Hold at Societe Generale » 06:08
10/26/20
10/26
06:08
10/26/20
06:08
FTI

TechnipFMC

$6.48 /

-0.385 (-5.61%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTI TechnipFMC
$6.48 /

-0.385 (-5.61%)

FTI TechnipFMC
$6.48 /

-0.385 (-5.61%)

05:32 Today Societe Generale
TechnipFMC upgraded to Buy from Hold at Societe Generale
10/13/20 Jefferies
TechnipFMC upgraded to Hold from Underperform at Jefferies
10/01/20 BMO Capital
TechnipFMC initiated with a Market Perform at BMO Capital
08/07/20 HSBC
TechnipFMC downgraded to Hold from Buy at HSBC
FTI TechnipFMC
$6.48 /

-0.385 (-5.61%)

FTI TechnipFMC
$6.48 /

-0.385 (-5.61%)

FTI TechnipFMC
$6.48 /

-0.385 (-5.61%)

Initiation
Gibson Energy initiated with an Overweight at Wells Fargo » 06:08
10/26/20
10/26
06:08
10/26/20
06:08
GBNXF

Gibson Energy

$0.00 /

+ (+0.00%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBNXF Gibson Energy
$0.00 /

+ (+0.00%)

GBNXF Gibson Energy
$0.00 /

+ (+0.00%)

09/10/20 Raymond James
Gibson Energy downgraded to Market Perform from Outperform at Raymond James
08/28/20 CIBC
NCIB makes sense for Gibson, says CIBC
08/06/20 CIBC
Gibson Energy price target raised to C$25 from C$24 at CIBC
08/06/20 RBC Capital
Gibson Energy price target raised to C$27 from C$25 at RBC Capital

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.